【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Pipeline portfolio
PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 07: Market segmentation by disease type
• Rheumatoid arthritis
• Osteoarthritis
• Osteoporosis
• Psoriatic arthritis
• Ankylosing spondylitis
• Fibromyalgia
PART 08: Global rheumatoid arthritis drugs market
• Market overview
PART 09: Global osteoarthritis drugs market
• Market overview
PART 10: Global osteoporosis drugs market
• Market overview
PART 11: Global ankylosing spondylitis drugs market
• Market overview
PART 12: Global psoriatic arthritis drugs market
• Market overview
PART 13: Global fibromyalgia drugs market
• Market overview
PART 14: Market segmentation by type of molecule
• Biologics
• Small molecules
PART 15: Market segmentation by route of administration
• Parenteral
• Topical
• Oral
PART 16: Geographical segmentation
• Global musculoskeletal disorder therapeutics market by geography 2015-2020
• Musculoskeletal disorders therapeutics market in Americas
• Musculoskeletal disorders therapeutics market in EMEA
• Musculoskeletal disorders therapeutics market in APAC
PART 17: Market drivers
• High growth potential of mAbs
• Unmet needs of therapeutics
• Tentative approval of advanced drugs
• Technological advancements in medical imaging
• Combination therapies
PART 18: Impact of drivers
PART 19: Market challenges
• Non-adherence to treatment regimen
• Growing preference toward surgeries
• Multiple patent expiries
PART 20: Impact of drivers and challenges
PART 21: Market trends
• Focus on regenerative medicines
• Ongoing active clinical trials for biosimilars
• Growing focus toward abuse-resistant novel drugs
PART 22: Vendor landscape
• Competitive scenario
PART 23: Key vendor analysis
• AbbVie
• Johnson & Johnson
• Amgen
• Pfizer
• F. Hoffmann-La Roche
• Eli Lilly
• Other prominent vendors
PART 24: Appendix
• List of abbreviations
PART 25: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Key customer segments for musculoskeletal disorder therapeutics
Exhibit 03: Impact of biologics on various sectors
Exhibit 04: Pipeline portfolio: Global rheumatoid arthritis drugs market
Exhibit 05: Pipeline portfolio: Global osteoarthritis drugs market
Exhibit 06: Pipeline portfolio: Global osteoporosis drugs market
Exhibit 07: Pipeline portfolio: Global psoriatic arthritis drugs market
Exhibit 08: Pipeline portfolio: Global fibromyalgia drugs market
Exhibit 09: Pipeline portfolio: Global ankylosing spondylitis drugs market
Exhibit 10: Global musculoskeletal disorder therapeutics market 2015-2020 ($ billions)
Exhibit 11: Patient assistance programs offered by companies
Exhibit 12: CAM therapies for rheumatoid arthritis
Exhibit 13: Five forces analysis
Exhibit 14: Segmentation of global musculoskeletal disorder therapeutics market
Exhibit 15: Segmentation of global musculoskeletal disorder therapeutics market by revenue 2015
Exhibit 16: Opportunities in rheumatoid arthritis drugs industry
Exhibit 17: Global rheumatoid arthritis drugs market 2015-2020 ($ billions)
Exhibit 18: Unmet medical needs with current osteoarthritis treatments
Exhibit 19: Global osteoarthritis drugs market 2015-2020 ($ billions)
Exhibit 20: Global osteoporosis drugs market 2015-2020 ($ billions)
Exhibit 21: Global ankylosing spondylitis drugs market 2015-2020 ($ billions)
Exhibit 22: Global psoriatic arthritis drugs market 2015-2020 ($ billions)
Exhibit 23: Global fibromyalgia drugs market 2015-2020 ($ billions)
Exhibit 24: Segmentation of global musculoskeletal disorder therapeutics market by type of molecules 2015
Exhibit 25: Segmentation of global musculoskeletal disorder therapeutics market by ROA 2015
Exhibit 26: Global musculoskeletal disorder therapeutics market by geography 2015-2020
Exhibit 27: Global musculoskeletal disorder therapeutics market segmentation by geography 2015-2020 ($ billions)
Exhibit 28: Global share of musculoskeletal disorders therapeutics market by geography 2015
Exhibit 29: Global musculoskeletal disorder therapeutics market: Country analysis based on revenue and growth rate
Exhibit 30: Musculoskeletal disorders therapeutics market in Americas 2015-2020 ($ billions)
Exhibit 31: Musculoskeletal disorders therapeutics market in EMEA 2015-2020 ($ billions)
Exhibit 32: Musculoskeletal disorders therapeutics market in APAC 2015-2020 ($ billions)
Exhibit 33: Few of the late-stage mAbs under development for various musculoskeletal disorders
Exhibit 34: Impact of drivers
Exhibit 35: Approval and patent expiries of top selling biologics
Exhibit 36: Impact of drivers and challenges
Exhibit 37: Key vendors ranking 2015
Exhibit 38: Geographical presence of key vendors
Exhibit 39: Competitive scenario of global musculoskeletal disorder therapeutics market vendors 2015-2020
Exhibit 40: AbbVie: YoY revenue and growth rate of Humira 2013-2015 ($ billions)
Exhibit 41: AbbVie: Geographical segmentation of Humira 2015
Exhibit 42: AbbVie: Metrics analysis
Exhibit 43: Key products in musculoskeletal disorders market with 2015 revenues
Exhibit 44: Johnson & Johnson: YoY revenue and growth rate of Remicade 2013-2015 ($ billions)
Exhibit 45: Johnson & Johnson: YoY revenue and growth rate of Simponi/Simponi Aria 2013-2015 ($ billions)
Exhibit 46: Johnson & Johnson: YoY revenue and growth rate of Stelara 2013-2015 ($ billions)
Exhibit 47: Johnson & Johnson: Metrics analysis
Exhibit 48: Amgen: YoY revenue and growth rate of Enbrel (US and Canada) 2013-2015 ($ billions)
Exhibit 49: Amgen: YoY revenue and growth rate of Prolia 2013-2015 ($ billions)
Exhibit 50: Amgen: Geographical segmentation of Prolia 2015
Exhibit 51: Amgen: Metrics analysis
Exhibit 52: Key products in musculoskeletal disorders market with 2015 revenues
Exhibit 53: Pfizer: YoY revenue and growth rate of Lyrica 2013-2015 ($ billions)
Exhibit 54: Pfizer: YoY revenue and growth rate of Enbrel (outside US and Canada) 2013-2015 ($ billions)
Exhibit 55: Pfizer: YoY revenue and growth rate of Celebrex 2013-2015 ($ billions)
Exhibit 56: Pfizer: YoY revenue and growth rate of Xeljanz 2013-2015 ($ millions)
Exhibit 57: Pfizer: Metrics analysis
Exhibit 58: F. Hoffmann-La Roche: YoY revenue and growth rate of MabThera/Rituxan 2013-2015 ($ billions)
Exhibit 59: F. Hoffmann-La Roche: Geographical segmentation of MabThera/Rituxan by revenue 2015
Exhibit 60: F. Hoffmann-La Roche: YoY revenue and growth rate of Actemra/RoActemra 2013-2015 ($ billions)
Exhibit 61: F. Hoffmann-La Roche: Geographical segmentation of Actemra/RoActemra by revenue 2015
Exhibit 62: F. Hoffmann-La Roche: Metrics analysis
Exhibit 63: Eli Lilly: YoY revenue and growth rate of Cymbalta 2013-2015 ($ billions)
Exhibit 64: Eli Lilly: YoY revenue and growth rate of Evista 2013-2015 ($ billions)
Exhibit 65: Eli Lilly: Geographical segmentation of Evista 2015
Exhibit 66: Eli Lilly: YoY revenue and growth rate of Forteo 2013-2015 ($ billions)
Exhibit 67: Eli Lilly: Geographical segmentation of Forteo 2015
Exhibit 68: Eli Lilly: Metrics analysis
【レポート販売概要】
■ タイトル：筋骨格障害治療薬の世界市場：リウマチ性関節炎、骨関節炎、骨粗鬆症、乾癬性関節炎、強直性脊椎炎、線維筋痛症■ 英文：Global Musculoskeletal Disorders Therapeutics Market 2016-2020
■ 発行日：2016年8月31日
■ 調査会社：Technavio
■ 商品コード：IRTNTR10170
■ 調査対象地域：グローバル
- 口腔衛生製品（口腔衛生用品）のグローバル市場（2014-2018）About Oral Hygiene There are many problems such as dental caries and tooth decay that affect the health of teeth. Treatment of such oral problems involves a high expenditure in case of further deterioration. The players in the Global Oral Hygiene market have been proactive in understanding the consumers by following a market- and consumer-driven approach. This has enabled them to develop innovativ …
- 急性脊髄損傷：グローバル臨床試験レビュー（2014年上半期）Acute Spinal Cord Injury Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Acute Spinal Cord Injury Global Clinical Trials Review, H1, 2014" provides data on the Acute Spinal Cord Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Spinal Cord Injury. It includes an overview of the trial num …
- インバータエアコンの世界市場2016-2020About Inverter Technology Air Conditioner Conventional air conditioner compressors can run at only one speed. Therefore, these compressors turn on and off at intervals to maintain the temperature inside an air conditioner. This results in high energy consumption. However, inverter technology air conditioner compressors can run at different speeds depending on the load required by the air condition …
- ポリウレタン分散の世界市場予測（～2024年）“Increasing demand from automobile, textile and leather industries to drive the overall growth of polyurethane dispersion market”The polyurethane dispersion (PUDs) market size is expected to grow from USD 2.4 billion in 2019 to USD 3.4 billion by 2024, at a CAGR of 7.1% during the forecast period. The PUDs market is driven by various factors, such as high demand from textile & leather industry, an …
- フローサイトメトリーの世界市場分析：技術別（セルベース、ビーズベース）、用途別（研究、産業、臨床）、エンドユーザー別（商業用、病院、学術、臨床研究）、製品･サービス別、セグメント予測、2014-2025The global flow cytometry market is expected to reach USD 8.0 billion by 2025, according to a new study by Grand View Research, Inc. The increasing incidence of infectious diseases and cancer is expected to upsurge the demand for flow cytometers for use in disease diagnosis over the coming years. In addition, higher number of physicians is inclined toward the usage of autologous and allogenic stem …
- 自動車サンルーフの世界市場2017-2021About Automotive SunroofAutomotive sunroofs may be fixed, vent, or sliding roofs that allow light and fresh air to enter the vehicle and also protects against the sun and wind. They can be operated manually or can be driven by motors. They are available in different sizes, shapes, and styles. Technavio’s analysts forecast the global automotive sunroof market to grow at a CAGR of 11.22% during the …
- 世界の印刷トナー市場：製品別、地域別Global Printing Toners Market: About this market Technavio’s printing toners market analysis considers sales from both monochrome printing toners and color printer toner products. Our study also finds the sales of printing toners in APAC, Europe, MEA, North America, and South America. In 2019, the monochrome printing toners segment had a significant market share, and this trend is expected to cont …
- 世界の医療産業におけるIoT（モノのインターネット）市場2016-2020About the Internet of Things (IoT) Market in Healthcare Sector IoT is a web of physical devices connected to the Internet, enabled by sensors and software to collect and transmit data. Using IoT users can collect massive amount of data and convert into meaningful information by with the help of advance analytics techniques. The concept of IoT has evolved with the introduction of automated machines …
- 人工肩関節置換術：企業と競争環境MediPoint: Total Shoulder Replacement - Current and Future Players Summary GlobalData has released its medical devices report, "MediPoint: Total Shoulder Replacement - Current and Future Players". The report is an essential source of information and analysis on the global total shoulder replacement market. Although sluggish economic growth has hindered the large-joint replacement market in the Uni …
- Alberta Oilsands Inc.：石油・ガスの開発・生産動向及びコスト分析- 2012Alberta Oilsands Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Alberta Oilsands Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for …
- クラウドインフラ管理：企業とソリューション2013（Cloud Infrastructure Management: Companies and Solutions 2013）The cloud infrastructure ecosystem represents a large-scale distributed computing paradigm that is driven by economies of scale in which a pool of abstracted, virtualized, dynamically scalable, managed computing power, storage, platforms, and services are delivered on demand to external customers over the Internet. Cloud infrastructure is best known today for support for Infrastructure as a Servic …
- 世界の仮想データセンター市場：ハードウェア及びソフトウェアDatacenter virtualization represents a flexible, elastic and cost effective alternative physical datacenter operations. Datacenter virtualization is achieved through two methods. The first is virtualization of computing infrastructure, storage networks, and associated security and management components. Server virtualization, followed by storage, and then network are the precursors leading virtual …
- GTL（ガス・トゥー・リキッド）市場分析：Analyzing Gas to Liquids MarketThe GTL industry can be viewed as an alternative to oil refining. The basic technology of the industry dates back to 1923 when two German scientists, Franz Fischer and Hans Tropsch (FT), invented a process that could convert natural gas to a hydrocarbon mixture which could then be upgraded into petroleum products. The FT technology provides an alternative to traditional crude oil refining, as liqu …
- プロピレングリコールの世界市場予測（～2021年）The global propylene glycol market was valued at USD 3.47 Billion in 2016, and is projected to reach USD 4.60 Billion by 2021, at a CAGR of 5.8% from 2016 to 2021. Growing automotive industry in Asia-Pacific and eco-friendly production process of bio-based propylene glycol are expected drive the market during the forecast period. On the basis of source, the global propylene glycol market is classi …
- 装甲車の世界市場予測（～2023年）“The requirement for effective and successful defense operations is the key factor influencing the growth of the armored vehicles market across the globe.”The armored vehicles market is projected to grow from USD 14.3 billion in 2018 to USD 16.8 billion by 2023, at a CAGR of 3.25% from 2018 to 2023. Growing demand for armored vehicles due to rise in the instances of cross-border conflicts and incr …
